ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag industry drug development policy collaboration

How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Tag, You're It
Carina Storrs | Feb 1, 2014 | 7 min read
A guide to DNA-encoded libraries for drug discovery
Best Places to Work Industry, 2011
Hannah Waters | May 1, 2011 | 9 min read
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
The UK Pharmaceutical Industry Braces for Brexit
Diana Kwon | Oct 12, 2018 | 9 min read
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.
Medicines for the World
Suerie Moon and Ellen â??t Hoen and Suerie Moon and Ellen â??t Hoen | Oct 1, 2012 | 5 min read
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Cuban-U.S. Research Collaborations Easier Now
Kerry Grens | Oct 18, 2016 | 1 min read
President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.
Minding the Drug Development Gap
Edward Spack | Nov 6, 2005 | 6 min read
Twenty-five years after the enactment of the Bayh-Dole Act, scientists and administrators in academia who are interested in moving bench discoveries to the clinic are learning what travelers in London's subway system already know: It's important to "mind the gap."
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Government To Industry: Join War On Drugs
Diana Morgan | Nov 25, 1990 | 8 min read
NIDA offers financial and regulatory incentives, but reluctant pharmaceutical companies are worried about the legal risks WASHINGTON--The federal government wants to persuade the pharmaceutical industry to join its war on illegal drugs. At a two-day conference here this week the two sides will discuss financial and regulatory inducements to drug companies that create medications to fight mental illness to join the battle. Agencies within the Public Health Service are hoping that pharmaceutica

Run a Search

ADVERTISEMENT